Revolution Medicines, Inc. Operating Lease Liabilities decreased by 1.6% to $140.02M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.4%, from $121.36M to $140.02M. Over 5 years (FY 2020 to FY 2025), Operating Lease Liabilities shows an upward trend with a 37.5% CAGR.
An increase reflects long-term expansion of the leased asset base, while a decrease indicates a reduction in long-term lease commitments.
This represents the portion of operating lease obligations that are due beyond the next twelve months. It reflects the l...
Standard long-term liability for companies with significant real estate or equipment footprints.
operating_lease_liabilities_non_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $27.57M | $26.83M | $60.42M | $59.58M | $58.92M | $58.18M | $57.43M | $57.68M | $57.54M | $57.09M | $80.58M | $79.86M | $79.08M | $78.31M | $122.97M | $121.36M | $119.70M | $142.14M | $142.23M | $140.02M |
| QoQ Change | — | -2.7% | +125.2% | -1.4% | -1.1% | -1.3% | -1.3% | +0.4% | -0.2% | -0.8% | +41.1% | -0.9% | -1.0% | -1.0% | +57.0% | -1.3% | -1.4% | +18.7% | +0.1% | -1.6% |
| YoY Change | — | — | — | — | +113.7% | +116.9% | -4.9% | -3.2% | -2.3% | -1.9% | +40.3% | +38.5% | +37.4% | +37.2% | +52.6% | +52.0% | +51.4% | +81.5% | +15.7% | +15.4% |